EP2605757
Samsetningar sem eru nálbúfín að stofni til og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
18.8.2011EP published:
1.7.2015EP application number:
11758519.0
EP translation filed:
21.9.2015Grant published:
15.10.2015EPO information:
European Patent Register
Max expiry date:
17.8.2031Expiry date:
17.8.2020
Title:
NALBUPHINE-BASED FORMULATIONS AND USES THEREOF
Timeline
Today
18.8.2011EP application
1.7.2015EP Publication
21.9.2015Translation submitted
15.10.2015Registration published
17.8.2020Expires
Owner
Name:
Debregeas Et Associes PharmaAddress:
79 rue de Miromesnil, 75008, Paris, FR
Inventor
Name:
LEBON, ChristopheAddress:
Rouvres, FR
Name:
SUPLIE, PascalAddress:
Montaure, FR
Name:
PAUL, David OlivierAddress:
Dreux, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
1056689Date:
20.8.2010Country:
FR
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 9/50, A61K 31/485, A61K 47/10, A61K 47/36, A61K 47/26, A61K 47/02, A61P 25/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.9.2015
Expires: 17.8.2016
Payer: Árnason Faktor
Number: 6
Paid: 20.6.2016
Expires: 17.8.2017
Payer: Árnason Faktor
Number: 7
Paid: 26.6.2017
Expires: 17.8.2018
Payer: Árnason Faktor
Number: 8
Paid: 17.7.2018
Expires: 17.8.2019
Payer: Árnason Faktor
Number: 9
Paid: 23.8.2019
Expires: 17.8.2020
Payer: Tego ehf.